LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Measurement of Omega-3 Fatty Acids More Reliable in Red Blood Cells Than in Plasma

By LabMedica International staff writers
Posted on 17 Jul 2013
Print article
Findings released in a recently published study showed that omega-3 fatty acid levels in red blood cells were less susceptible to dietary influences and, therefore, represented a better matrix for its measurement than did plasma.

Investigators at Health Diagnostic Laboratory, Inc. (Richmond, VA, USA) compared the affect of dietary fish oil and fish oil supplements on measurement of blood omega-3 fatty acid levels in a study population comprising 20 healthy volunteers.

The volunteers were given four capsules containing 3.6 grams of omega-3 fatty acids alongside a standard breakfast. Blood samples were drawn six times over the course of 24 hours, and the investigators monitored eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) levels in plasma and red blood cells. At six hours after capsule intake, the plasma concentration of EPA and DHA had increased by 47%, while the plasma EPA and DHA percentage of total fatty acids increased by 19%. In contrast, levels of EPA and DHA in red blood cells did not change from baseline values. By 24 hours after capsule intake, plasma EPA and DHA levels were 10-fold greater than those in red blood cells.

"Although some experts question the value of omega-3 fatty acid supplementation for reducing risk of coronary heart disease, medical testing for omega-3 fatty acid status has become more common and clinicians have a choice of whether to use red blood cell or plasma-based assays," said senior author Dr. William S. Harris, a senior research scientist at Health Diagnostic Laboratory, Inc. "While different assays have different performance characteristics, fasting requirements, and sensitivities, it is important for clinicians to choose the appropriate testing method. This research backs our hypothesis that the red blood cell omega-3 assay is the preferred sample type for the assessment of fatty acids in the body."

The study was published in the May 9, 2013, online edition of the Journal of Clinical Lipidology.

Related Links:
Health Diagnostic Laboratory, Inc.


Gold Member
Troponin T QC
Troponin T Quality Control
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Total 25-Hydroxyvitamin D₂ & D₃ Assay
Total 25-Hydroxyvitamin D₂ & D₃ Assay
New
Anti-HHV-6 IgM Assay
anti-HHV-6 IgM ELISA (semiquant.)

Print article

Channels

Molecular Diagnostics

view channel
Image: The experimental blood test accurately indicates severity and predicts potential recovery from spinal cord injury (Photo courtesy of 123RF)

Blood Test Identifies Multiple Biomarkers for Rapid Diagnosis of Spinal Cord Injury

The National Institutes of Health estimates that 18,000 individuals in the United States sustain spinal cord injuries (SCIs) annually, resulting in a staggering financial burden of over USD 9.... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more

Industry

view channel
Image: Tumor-associated macrophages visualized using the Multiomic LS Assay (Photo courtesy of ACD)

Leica Biosystems and Bio-Techne Expand Spatial Multiomic Collaboration

Bio-Techne Corporation (Minneapolis, MN, USA) has expanded the longstanding partnership between its spatial biology brand, Advanced Cell Diagnostics (ACD, Newark, CA, USA), and Leica Biosystems (Nussloch,... Read more
Sekisui Diagnostics UK Ltd.